Jeffersonville, PA, United States of America

Yong-Mi Choi


Average Co-Inventor Count = 3.6

ph-index = 2

Forward Citations = 36(Granted Patents)


Company Filing History:


Years Active: 1995-1996

Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Yong-Mi Choi

Introduction

Yong-Mi Choi is a notable inventor based in Jeffersonville, PA (US). She has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target cholesterol levels in the body. With a total of 3 patents to her name, her work has the potential to impact health treatments significantly.

Latest Patents

One of her latest patents is focused on phosphonate derivatives of lipophilic amines. This invention relates to a class of novel phosphonate derivatives that exhibit squalene synthase inhibition properties. More specifically, the compounds are bis aryl cycloalkylamino and azacycloalkyl phosphonates. These compounds are designed to reduce levels of serum cholesterol in the body without significantly affecting mevalonic metabolite synthesis. Additionally, this invention includes pharmacological compositions and methods for treating high serum cholesterol levels using these compounds.

Another significant patent involves polyarylcarbamoylaza- and -carbamoylalkanedioic acids. This invention pertains to a class of novel dicarboxy amide derivatives of lipophilic amines, which also exhibit squalene synthase inhibition properties. The compounds are bis-aryl and/or heteroaryl alkyl or cycloalkylamino dicarboxy amides. Similar to her previous work, these compounds aim to lower serum cholesterol levels without adversely affecting mevalonic metabolite synthesis, along with related pharmacological compositions and treatment methods.

Career Highlights

Yong-Mi Choi is currently associated with Rhone-Poulenc Rorer Pharmaceuticals Inc., where she continues to innovate in the pharmaceutical sector. Her work is characterized by a strong focus on developing effective treatments for cholesterol management, showcasing her commitment to improving public health.

Collaborations

Throughout her career, Yong-Mi has collaborated with esteemed colleagues, including Henry W Pauls and Dilip V Amin. These partnerships have likely contributed to the success and advancement of her research and inventions.

Conclusion

Yong-Mi Choi's contributions to the field of pharmaceuticals through her innovative patents demonstrate her dedication to addressing critical health issues. Her work in developing compounds that effectively manage cholesterol levels highlights the importance of innovation in medical treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…